Warning letter
Amico Laboratories, Inc.: warning letter of Jan 3, 2008
FDA warning letter UCM1048453 · New Orleans District Office
Key facts
| Reference number | UCM1048453 |
|---|---|
| Company | Amico Laboratories, Inc. |
| Subject | CGMP/QSR/Medical Devices/Adulterated/Misbranded |
| Issue date | Jan 3, 2008 |
| Posted date | Jan 3, 2008 |
| Issuing office | New Orleans District Office |
| Product type | Devices |
| CFR sections cited | 803, 803.17, 862, 820, 820.40 |
| Country | 3 |
| Inspection city | Nashville |
| Inspection ZIP | 37209-2108 |
| Inspection start date | Sep 10, 2007 |
| Letter on fda.gov | web.archive.org |
At a glance
- 1–9 CFR sections cited
- OAI Linked inspection classification
- Yes Form FDA 483 issued
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA warning letters
FDA warning letters notify a firm of significant regulatory violations found during an inspection or review and request prompt corrective action.
Source: U.S. Food and Drug Administration (FDA), Warning Letters · Source date: